Status:
COMPLETED
Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome
Lead Sponsor:
Eli Lilly and Company
Conditions:
Turner Syndrome
Eligibility:
FEMALE
4-20 years
Phase:
PHASE4
Brief Summary
This is an extension study that will gather long-term data on the effect of early growth hormone (GH) treatment on adult height and other aspects of health and development in girls with Turner syndrom...
Eligibility Criteria
Inclusion
- Previously randomized in study B9R-US-GDFG (NCT00406926)
- Karyotype-proven Turner syndrome
Exclusion
- Immediate family members of study site personnel directly affiliated with the study
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2015
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT00266656
Start Date
December 1 2005
End Date
September 1 2015
Last Update
March 31 2017
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Childrens Hospital of Los Angeles
Los Angeles, California, United States, 90027
2
Children's Hospital
Aurora, Colorado, United States, 80045
3
Connecticut Children's Medical Center
Hartford, Connecticut, United States, 06106
4
Children's Hospital of Chicago Research Center
Chicago, Illinois, United States, 60611